Newron faces delay to would-be schizophrenia blockbusterNewron has been forced to delay the start of a pivotal trial of its schizophrenia candidate evenamide – Share XNewron faces delay to would-be schizophrenia blockbusterhttps://pharmaphorum.com/news/newron-faces-delay-to-would-be-schizophrenia-blockbuster/
